All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

147

Reset

147 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CAL101Phase 21 trial

    Calluna Pharma AS · Idiopathic Pulmonary Fibrosis

  • CHF 6001Phase 21 trial

    Chiesi Farmaceutici S.p.A. · Asthma

  • CHF10067Phase 21 trial

    Chiesi Farmaceutici S.p.A. · Idiopathic Pulmonary Fibrosis

  • CHF6333Phase 21 trial

    Chiesi Farmaceutici S.p.A. · Bronchiectasis

  • CMTX-101Phase 21 trial

    Clarametyx Biosciences, Inc. · Persistent Infection, Cystic Fibrosis

  • CSL787Phase 21 trial

    CSL Behring · Non-cystic Fibrosis Bronchiectasis

  • DIAG723Phase 21 trial

    Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension

  • DWN12088DWN12088 XmgPhase 21 trial

    Daewoong Pharmaceutical Co. LTD. · Idiopathic Pulmonary Fibrosis

  • ENV-101taladegibPhase 21 trial

    Endeavor Biomedicines, Inc. · Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease

  • ETD001Phase 21 trial

    Enterprise Therapeutics Ltd · Cystic Fibrosis

  • ETH47Phase 21 trial

    Ethris GmbH · Asthma (Diagnosis)

  • EXPD-101FXS7553Phase 21 trial

    Expedition Therapeutics, Inc · Chronic Obstructive Pulmonary Disease (COPD)

  • FB704APhase 21 trial

    Oneness Biotech Co., Ltd. · Severe Asthma

  • FrevecitinibPhase 21 trial

    Kinaset Therapeutics Inc · Severe Asthma

  • HRS-9821Phase 21 trial

    Guangdong Hengrui Pharmaceutical Co., Ltd · COPD

  • HSK50042Phase 21 trial

    Haisco Pharmaceutical Group Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)

  • JKN2304Phase 21 trial

    Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease), COPD

  • JKN24011Phase 21 trial

    Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease)

  • JKN2403Phase 21 trial

    Joincare Pharmaceutical Group Industry Co., Ltd · COPD (Chronic Obstructive Pulmonary Disease)

  • KIT2014Phase 21 trial

    Kither Biotech Srl · Chronic Obstructive Pulmonary Disease (COPD)

  • linvemastatFP-020Phase 21 trial

    Foresee Pharmaceuticals Co., Ltd. · Asthma (Diagnosis), Pulmonary Function, Moderate-to-Severe Asthma

  • LQ036Phase 21 trial

    Shanghai Novamab Biopharmaceuticals Co., Ltd. · Asthma

  • LTI-03Phase 21 trial

    Rein Therapeutics · Idiopathic Pulmonary Fibrosis (IPF)

  • MTX-463Phase 21 trial

    Mediar Therapeutics · Idiopathic Pulmonary Fibrosis

  • ND-003Phase 21 trial

    Shenzhen NewDEL Biotech, Co., Ltd · Idiopathic Pulmonary Fibrosis (IPF)

  • NHS7108Phase 21 trial

    Aimmune Nestlé Health Science US R&D, LLC · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality

  • NSI-8226Phase 21 trial

    Uniquity One (UNI) · Asthma

  • ORJ-001Phase 21 trial

    Oorja Bio, Inc. · Idiopathic Pulmonary Fibrosis

  • PF-07868489Phase 21 trial

    Pfizer · Pulmonary Arterial Hypertension

  • PIPE-791Phase 21 trial

    Contineum Therapeutics · Idiopathic Pulmonary Fibrosis

  • RCT2100Phase 21 trial

    ReCode Therapeutics · Cystic Fibrosis

  • REGN13335Phase 21 trial

    Regeneron · Pulmonary Arterial Hypertension (PAH)

  • RESP302Phase 21 trial

    Thirty Respiratory Limited · Non-Cystic Fibrosis Bronchiectasis

  • RESP303Phase 21 trial

    Thirty Respiratory Limited · Non-Cystic Fibrosis Bronchiectasis

  • RIG-101Phase 21 trial

    RIGImmune Inc. · Healthy Adult Participants, Asthma Exacerbation, Safety and Efficacy

  • RO7275887Phase 21 trial

    Roche (Genentech) · Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants

  • RO7830698Phase 21 trial

    Roche (Genentech) · Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants

  • ROC-101Phase 21 trial

    AllRock Bio, Inc. · Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease

  • RSP-1502Phase 21 trial

    Respirion Pharmaceuticals Pty Ltd · Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa

  • RSS0343Phase 21 trial

    Reistone Biopharma Company Limited · Chronic Obstructive Pulmonary Disease

  • SB17170Phase 21 trial

    SPARK Biopharma · IPF, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)

  • SHR4597Phase 21 trial

    Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma

  • SPL84Phase 21 trial

    SpliSense Ltd. · Cystic Fibrosis

  • SV001Phase 21 trial

    Shanghai Synvida Biotechnology Co.,Ltd. · Idiopathic Pulmonary Fibrosis(IPF)

  • SYH2059Phase 21 trial

    InnovStone Therapeutics Limited · Idiopathic Pulmonary Fibrosis

  • SYH9061Phase 21 trial

    CSPC-NBP Pharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis

  • TQC3721Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Pulmonary Disease, Chronic Obstructive

NewerPage 3 of 3

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.